Assignee
CELLWORKS GROUP INC
US·1 granted patent·2 pending applications·1 citations·filing 2014–2022
Top patents by PatentIndex Score
3 records- 0152US10098880B2Combination of nelfinavir, metformin and rosuvastatin for treating cancer caused by aberrations in PTEN/TP53CELLWORKS GROUP INC·Filed 2015·Granted Oct 16, 2018·1 cites·7 claims
- 0246US2022305000A1Combination Comprising Chloroquine, Metformin and Statin for Management of Cancer, Composition and Methods ThereofCELLWORKS GROUP INC·Filed 2022·Application pending·0 cites
- 0335US2016058751A1Composition and method for treating cancerCELLWORKS GROUP INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLWORKS GROUP INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →